Tutt AL - Search Results

1

Control of established melanoma by CD27 stimulation is associated with enhanced effector function and persistence, and reduced PD-1 expression of tumor infiltrating CD8(+) T cells.

Roberts DJ, Franklin NA, Kingeter LM, Yagita H, Tutt AL, Glennie MJ, Bullock TN. Roberts DJ, et al. Among authors: tutt al. J Immunother. 2010 Oct;33(8):769-79. doi: 10.1097/CJI.0b013e3181ee238f. J Immunother. 2010. PMID: 20842060 Free PMC article.

2

Agonist anti-human CD27 monoclonal antibody induces T cell activation and tumor immunity in human CD27-transgenic mice.

He LZ, Prostak N, Thomas LJ, Vitale L, Weidlick J, Crocker A, Pilsmaker CD, Round SM, Tutt A, Glennie MJ, Marsh H, Keler T. He LZ, et al. J Immunol. 2013 Oct 15;191(8):4174-83. doi: 10.4049/jimmunol.1300409. Epub 2013 Sep 11. J Immunol. 2013. PMID: 24026078

3

Eradication of lymphoma by CD8 T cells following anti-CD40 monoclonal antibody therapy is critically dependent on CD27 costimulation.

French RR, Taraban VY, Crowther GR, Rowley TF, Gray JC, Johnson PW, Tutt AL, Al-Shamkhani A, Glennie MJ. French RR, et al. Among authors: al shamkhani a, tutt al. Blood. 2007 Jun 1;109(11):4810-5. doi: 10.1182/blood-2006-11-057216. Epub 2007 Feb 20. Blood. 2007. PMID: 17311995 Free article.

4

T cell immunity to lymphoma following treatment with anti-CD40 monoclonal antibody.

Tutt AL, O'Brien L, Hussain A, Crowther GR, French RR, Glennie MJ. Tutt AL, et al. J Immunol. 2002 Mar 15;168(6):2720-8. doi: 10.4049/jimmunol.168.6.2720. J Immunol. 2002. PMID: 11884438

5

Expression and costimulatory effects of the TNF receptor superfamily members CD134 (OX40) and CD137 (4-1BB), and their role in the generation of anti-tumor immune responses.

Taraban VY, Rowley TF, O'Brien L, Chan HT, Haswell LE, Green MH, Tutt AL, Glennie MJ, Al-Shamkhani A. Taraban VY, et al. Among authors: al shamkhani a, tutt al. Eur J Immunol. 2002 Dec;32(12):3617-27. doi: 10.1002/1521-4141(200212)32:12<3617::AID-IMMU3617>3.0.CO;2-M. Eur J Immunol. 2002. PMID: 12516549 Free article.

6

Activation and preferential expansion of rat cytotoxic (CD8) T cells in vitro and in vivo with a bispecific (anti-TCR alpha/beta x anti-CD2) F(ab')2 antibody.

Tutt AL, Reid R, Wilkins BS, Glennie MJ. Tutt AL, et al. J Immunol. 1995 Sep 15;155(6):2960-71. J Immunol. 1995. PMID: 7673714

7

CD40 antibody evokes a cytotoxic T-cell response that eradicates lymphoma and bypasses T-cell help.

French RR, Chan HT, Tutt AL, Glennie MJ. French RR, et al. Among authors: tutt al. Nat Med. 1999 May;5(5):548-53. doi: 10.1038/8426. Nat Med. 1999. PMID: 10229232

8

Immunotherapy targeting inhibitory Fcγ receptor IIB (CD32b) in the mouse is limited by monoclonal antibody consumption and receptor internalization.

Williams EL, Tutt AL, Beers SA, French RR, Chan CH, Cox KL, Roghanian A, Penfold CA, Butts CL, Boross P, Verbeek JS, Cragg MS, Glennie MJ. Williams EL, et al. Among authors: tutt al. J Immunol. 2013 Oct 15;191(8):4130-40. doi: 10.4049/jimmunol.1301430. Epub 2013 Sep 11. J Immunol. 2013. PMID: 24026082

9

CD11c provides an effective immunotarget for the generation of both CD4 and CD8 T cell responses.

Castro FV, Tutt AL, White AL, Teeling JL, James S, French RR, Glennie MJ. Castro FV, et al. Among authors: tutt al. Eur J Immunol. 2008 Aug;38(8):2263-73. doi: 10.1002/eji.200838302. Eur J Immunol. 2008. PMID: 18651710 Free article.

10

CD40 ligation for immunotherapy of solid tumours.

Todryk SM, Tutt AL, Green MH, Smallwood JA, Halanek N, Dalgleish AG, Glennie MJ. Todryk SM, et al. Among authors: tutt al. J Immunol Methods. 2001 Feb 1;248(1-2):139-47. doi: 10.1016/s0022-1759(00)00349-5. J Immunol Methods. 2001. PMID: 11223075

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

56 results

Search Page

Filters